Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 19;21(18):6874.
doi: 10.3390/ijms21186874.

Leukoplakia and Immunology: New Chemoprevention Landscapes?

Roberto Grigolato  1 , Maria Eleonora Bizzoca  2 , Luca Calabrese  3 , Stefania Leuci  4 , Michele Davide Mignogna  4 , Lorenzo Lo Muzio  2   5
Affiliations
Review

Leukoplakia and Immunology: New Chemoprevention Landscapes?

Roberto Grigolato et al. Int J Mol Sci. .

Abstract

Oral potentially malignant disorders (OPMDs) comprise a range of clinical-pathological alterations frequently characterized by an architectural and cytological derangements upon histological analysis. Among them, oral leukoplakia is the most common type of these disorders. This work aims to analyze the possible use of drugs such as immunochemopreventive agents for OPMDs. Chemoprevention is the use of synthetic or natural compounds for the reversal, suppression, or prevention of a premalignant lesion conversion to malignant form. Experimental and in vivo data offer us the promise of molecular prevention through immunomodulation; however, currently, there is no evidence for the efficacy of these drugs in the chemoprevention action. Alternative ways to deliver drugs, combined use of molecules with complementary antitumor activities, diet influence, and better definition of individual risk factors must also be considered to reduce toxicity, improve compliance to the protocol treatment and offer a better individualized prevention. In addition, we must carefully reconsider the mode of action of many traditional cancer chemoprevention agents on the immune system, such as enhancing immunosurveillance and reversing the immune evasion. Several studies emphasize the concept of green chemoprevention as an alternative approach to accent healthy lifestyle changes in order to decrease the incidence of HNSCC.

Keywords: HNSCC; Leukoplakia; OPMDs; cancer; chemoprevention; immunology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Warnakulasuriya S., Johnson N.W., van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J. Oral Pathol. Med. 2007;36:575–580. doi: 10.1111/j.1600-0714.2007.00582.x. - DOI - PubMed
    1. Warnakulasuriya S., Ariyawardana A. Malignant transformation of oral leukoplakia: A systematic review of observational studies. J. Oral Pathol. Med. 2016;45:155–166. doi: 10.1111/jop.12339. - DOI - PubMed
    1. De la Cour C.D., Sperling C.D., Belmonte F., Syrjanen S., Kjaer S.K. Human papillomavirus prevalence in oral potentially malignant disorders: Systematic review and meta-analysis. Oral Dis. 2020 doi: 10.1111/odi.13322. - DOI - PubMed
    1. Chaves A.L.F., Silva A.G., Maia F.M., Lopes G.F.M., De Paulo L.F.B., Muniz L.V., Dos Santos H.B., Soares J.M.A., Souza A.A., De Oliveira Barbosa L.A., et al. Reduced CD8(+) T cells infiltration can be associated to a malignant transformation in potentially malignant oral epithelial lesions. Clin. Oral Investig. 2019;23:1913–1919. doi: 10.1007/s00784-018-2622-8. - DOI - PubMed
    1. Villa A., Celentano A., Glurich I., Borgnakke W.S., Jensen S.B., Peterson D.E., Delli K., Ojeda D., Vissink A., Farah C.S. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies. Oral Dis. 2019;25(Suppl. S1):64–78. doi: 10.1111/odi.13087. - DOI - PMC - PubMed

MeSH terms

Substances